LON:VLG

Venture Life Group Final Earnings Results & Report

Venture Life Group logo
GBX 69.14 +0.14 (+0.20%)
As of 12:37 PM Eastern

Venture Life Group reported Final earnings on September 29, 2026. The company reported EPS of GBX 4.10.

Earnings Announcement Details

Quarter
Final
Time
Before Market Opens

Venture Life Group EPS Results

Actual EPS
GBX 4.10
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Venture Life Group Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Conference Call Resources

Venture Life Group Final Earnings FAQ

Venture Life Group (LON:VLG) reported earnings of GBX 4.10 per share for Final. The report was announced on Tuesday, September 29, 2026.

Venture Life Group Earnings Headlines

Venture Life tightens share count with latest buyback
I'm handing you this one free
Elon Musk doesn't own the chip powering every Tesla, every Starlink dish, and every AI satellite he builds. He licenses it from one overlooked company. That supplier just got a major catalyst. Musk filed to launch 1,000,000 satellites, a move analyst Dylan believes could drive a 100X bigger bill for this chipmaker starting December 8th.tc pixel
See More Venture Life Group Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Venture Life Group? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Venture Life Group and other key companies, straight to your email.

About Venture Life Group

Venture Life is an international consumer self-care company focused on developing and commercialising products for the global self-care market helping our consumers live a longer healthier and more rewarding life. Headquartered in the UK, the Group's product portfolio includes Balance Activ in the area of women's intimate healthcare, Earol® supporting ENT care, Lift and Glucogel product ranges for energy and glucose management and hypoglycaemia, plus the Health & Her product range supporting the hormonal lifecycle. The products, which are typically recommended by pharmacists or healthcare practitioners, are available primarily through health & beauty stores, pharmacies, grocery multiples and e-commerce channels and are sold globally. In the UK, Ireland and the USA these are supplied direct by the company to retailers, elsewhere they are supplied by the Group's international distribution partners.

View Venture Life Group Profile